From discovery and development to commercial manufacturing, Syngene delivers science at scale for global pharma and biotech leaders.
With new expanded biologics capabilities in the U.S., and recognized by TIME Magazine as one of the world’s most sustainable companies, we combine scientific excellence with a deep commitment to the planet.
Connect with our leaders at CPHI Frankfurt and experience how our elite-level client-centricity has been a game changer for our partners worldwide.
Who You’ll Meet
Peter Bains
Managing Director and CEO
Caroline Hempstead
(Interim) Chief Commercial Officer
Alex Del Priore
Head of Large Molecules CDMO and (Interim) Head of Small Molecules CDMO
Mrinal Kammili
Head of Translational & Clinical Research
Gopi Krishnan
Vice President, Biopharmaceutical Manufacturing
Manoj Babu
Vice President, Business Development
Julien Hugon
Vice President, Business Development
Rajkumar Agarwal
General Manager,
Business Development
Manoj Babu
VP, Development Services
Pramuch Goel
Head of Corporate Affairs
Sudhir Nambiar
Vice President, Drug Substance Development and Manufacturing
Purushottam Singnurkar
Vice President Pharmaceutical Development
Julien Hugon
Vice President, Business Development
Rajkumar Agarwal
General Manager,
Business Development
Manoj Babu
VP, Development Services
The Syngene Advantage
Quality Focus
We are a fully digitized quality organization with a strong compliance track record with global regulators. Our facilities are US FDA, EMA, and PMDA approved, GLP certified, and AAALAC accredited.
Sustainability
As part of our commitment to sustainability, we recycled 63% water, consumed 92% renewable energy, and recycled 95% waste. We had zero environmental violations, and we won the TIME Magazine award for being the most sustainable pharma company in India, and in the Top 20 globally.
Green Chemistry Innovation
Implemented green chemistry across process design, process development, execution, and disposal phases. Also, reduced raw materials, solvents, waste, and disposal.
Robust Supply Chain
A network of 2500+ suppliers across 30+ countries, contracts with global partners, 24X7 local arrangements, and extended support to local partners. Plus, expanded biologics capabilities with our new facility in Bayview, Maryland, U.S.
Syngene’s Enduring Partnership with Bristol Myers Squibb: Advancing More Modalities Together
We look forward to meeting you in Frankfurt.
Let’s shape the future of science together.
Syngene International Limited. All rights reserved © 2025